X0508 4 2023-08-01 0000832489 GeoVax Labs, Inc. GOVX 0001903889 McKee Kelly T. Jr. C/O GEOVAX LABS, INC. 1900 LAKE PARK DR, SUITE 380 SMYRNA GA 30080 1 Chief Medical Officer 0 Stock Option 0.755 2023-08-01 4 A 0 15000 0 A 2033-12-07 Common Stock 15000 15000 D This stock option was granted on December 7, 2022, with the exercise price set based on the closing price of the underlying common stock as of that date. The stock option was granted contingent upon stockholder approval of an increase in common shares reserved for the company's stock incentive plan. Such approval occurred on August 1, 2023, so that is the date upon which the stock option is deemed granted pursuant to SEC reporting guidance. Stock option becomes exercisable in three equal annual installments on the first three anniversary dates of the grant. /s/ Kelly McKee 2023-08-14